Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Asymchem Laboratories’ New R&D Center Fully Operational

This article was originally published in PharmAsia News

Executive Summary

Asymchem Laboratories (Tianjin) recently opened its new R&D center in Tianjin. As one of the company's most important bases worldwide, the 10,000-square-meter facility will conduct new technology research on organic synthesis, medicinal chemistry, pharmaceutical preparation, as well as develop active pharmaceutical ingredient analysis and testing. Currently, Asymchem Laboratories' new GMP workshop and R&D center is operating at full capacity. The next phase will include construction of biolabs, a GMP pharmaceutical preparation workshop, a synthesis lab building and office block. The total value of the firm's output is expected to hit 2 billion yuan by 2010. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069118

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel